In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This report will, first, examine...
How far off is LeMaitre Vascular, Inc. (NASDAQ:LMAT) from its intrinsic value? Using the most recent financial data...
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and -2.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BURLINGTON, Mass., April 13, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary,.
BURLINGTON, Mass., April 30, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced.
There's been a notable change in appetite for LeMaitre Vascular, Inc. (NASDAQ:LMAT) shares in the week since its...
BURLINGTON, Mass., May 12, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare.
MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.
At this time, I would like to turn the call over to Mr. JJ Pellegrino, chief financial officer of LeMaitre Vascular. With me on today's call are our chairman and CEO, George LeMaitre; and our president, Dave Roberts.
BURLINGTON, Mass., March 04, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in March. David Roberts,.
Q4 2019 LeMaitre Vascular Inc Earnings Call
Intensifying competition in the U.S. retail drugstore market prompts Walgreens Boots (WBA) to diversify its product offerings.
Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.
LabCorp's (LH) Covance Drug Development delivers organic growth despite foreign currency headwind.
Q1 2020 LeMaitre Vascular Inc Earnings Call
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Hologic's (HOLX) latest offerings are set to improve flexibility and efficiency of laboratories.
BURLINGTON, Mass., Feb. 18, 2020 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 9th Annual SVB Leerink Global.
An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.